Vistakon Pharmaceuticals
15
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
6.7%
1 terminated/withdrawn out of 15 trials
93.3%
+6.8% vs industry average
80%
12 trials in Phase 3/4
50%
7 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Safety and Efficacy of a Glaucoma Drug Delivery System
Role: lead
A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs
Role: lead
Safety and Efficacy Study of a Eye Drop for Eye Allergy
Role: lead
Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers
Role: lead
Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Role: lead
Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers
Role: lead
Safety and Efficacy of a Drug Delivery System in Glaucoma
Role: lead
Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
Role: lead
Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
Role: lead
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
Role: lead
Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis
Role: lead
Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery
Role: collaborator
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis
Role: lead
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis
Role: lead
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator
Role: collaborator
All 15 trials loaded